|
|
Advertisement |
 |
|
|
Talent |
 |
Re-inventing Pharma's Talent Search |
Thinning talent pools, combined with evolving industry trends and job-seeker motivations, are testing traditional pharma hiring methods, where targeting new skills and capabilities must become the new norm
… /Read more/ |
|
|
|
Talent |
 |
|
|
|
|
 |
The Pharm Exec Podcast: Digital Medicine |
The Pharm Exec editors speak with Bill Carson, President & CEO of Otsuka Pharmaceutical Development & Commercialization, Inc. and Kabir Nath, President & CEO of Otsuka North America Pharmaceuticals about digital medicine, mental health therapies, and creating a smooth and collaborative relationship between R&D and commercial
… /Click here to listen/ |
|
|
|
Industry update |
//
Sanofi (Paris, France) appointed Ameet Nathwani, M.D. as Chief Digital Officer in addition to his current role of Executive Vice President, Chief Medical Officer.
//
Enterome (Paris, France and Cambridge, MA) appointed Jan Fagerberg M.D., Ph.D. as Chief Medical Officer and Catherine Mathis, Pharm.D. as Chief Development Officer.
//
Innate Pharma (Marseille, France) named Jennifer Butler as Executive Vice President and General Manager of Innate Pharma US Inc.
//
Dirk de Naeyer, formerly Head of Supply Chain at Kiadis Pharma (Amsterdam, The Netherlands) took up the position as the company's Chief Operations Officer, as a planned succession from Jan Feijen. Kiadis also appointed Martine Nolan as Head of Quality Assurance.
//
Dr. Athanasios Papadopoulos joined Emergex (Oxford, UK) as Chief Medical Officer.
//
ReViral (London, UK) appointed Seth Hetherington as Chief Medical Officer.
//
Hikma Pharmaceuticals (London, UK) announced the appointment of Cynthia Schwalm as an independent non-executive director, effective June 1, 2019.
//
Achilles Therapeutics (Stevenage, UK) named Dr Markus Dangl as Chief Scientific Officer.
//
Mundipharma (Cambridge, UK) appointed Patrice Grand as European Director of Corporate Communications.
//
InSphero (Schlieren, Switzerland) named Prof. Armin Wolf as Chief Scientific Officer.
|
|
|
|
|
|